Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil

Purpose: Middle-income countries like Brazil often have a dichotomous health care system in which patients may be treated in either public or private institutions that differ substantially in terms of level of access to diagnostic and therapeutic procedures. Patients and Methods: This was a prospect...

Full description

Bibliographic Details
Main Authors: Alexandre Boukai, Aline C. Gonçalves, Monica Padoan, Perla Andrade, Natalia Carvalho, Flavio Lemos, Thamires Almeida, Jonas Salem, Maria F. D. Gauí, Nelson Teich, Luiz H. Araujo
Format: Article
Language:English
Published: American Society of Clinical Oncology 2018-05-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.17.00143
_version_ 1811210613829926912
author Alexandre Boukai
Aline C. Gonçalves
Monica Padoan
Perla Andrade
Natalia Carvalho
Flavio Lemos
Thamires Almeida
Jonas Salem
Maria F. D. Gauí
Nelson Teich
Luiz H. Araujo
author_facet Alexandre Boukai
Aline C. Gonçalves
Monica Padoan
Perla Andrade
Natalia Carvalho
Flavio Lemos
Thamires Almeida
Jonas Salem
Maria F. D. Gauí
Nelson Teich
Luiz H. Araujo
author_sort Alexandre Boukai
collection DOAJ
description Purpose: Middle-income countries like Brazil often have a dichotomous health care system in which patients may be treated in either public or private institutions that differ substantially in terms of level of access to diagnostic and therapeutic procedures. Patients and Methods: This was a prospective, observational study to assess real-world data in 1,230 female patients with breast cancer who were treated in a private health care institution between 2012 and 2016 in Brazil. Results: Breast cancer in these patients mostly was diagnosed at early (79.0% stages I or II) or locally advanced (16.1% stage III) stages. The primary tumor was resected in 89.0% of cases, most often through breast-conserving surgery (55.1%). Patients with locally advanced disease received more aggressive therapy (eg, higher rates of mastectomy, axillary dissection and chemotherapy use) than patients with early-stage disease. The estimated 2-year overall survival (OS) was 95.3%. Survival was significantly longer among patients with stage I or II disease (2-year OS, 97.9% and 97.5%, respectively) than those with stage III or IV disease (89.4% and 69.5%, respectively; P < .01). Tumor grade was also correlated with OS in the overall cohort (P = .05); triple-negative status was only prognostic for patients with stage III disease (P < .01). Conclusion: The data provided aid understanding of the current scenario of breast cancer presentation and treatment in the Brazilian private health care system and may serve as a foundation to guide resource allocation. Our results reinforce the need to pursue adequate access to cancer care in low- and middle-income countries to optimize patient outcome.
first_indexed 2024-04-12T04:58:54Z
format Article
id doaj.art-1fa4e9c6c59247478d0370cc64167cc0
institution Directory Open Access Journal
issn 2378-9506
language English
last_indexed 2024-04-12T04:58:54Z
publishDate 2018-05-01
publisher American Society of Clinical Oncology
record_format Article
series Journal of Global Oncology
spelling doaj.art-1fa4e9c6c59247478d0370cc64167cc02022-12-22T03:47:03ZengAmerican Society of Clinical OncologyJournal of Global Oncology2378-95062018-05-01411010.1200/JGO.17.001431Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in BrazilAlexandre BoukaiAline C. GonçalvesMonica PadoanPerla AndradeNatalia CarvalhoFlavio LemosThamires AlmeidaJonas SalemMaria F. D. GauíNelson TeichLuiz H. AraujoPurpose: Middle-income countries like Brazil often have a dichotomous health care system in which patients may be treated in either public or private institutions that differ substantially in terms of level of access to diagnostic and therapeutic procedures. Patients and Methods: This was a prospective, observational study to assess real-world data in 1,230 female patients with breast cancer who were treated in a private health care institution between 2012 and 2016 in Brazil. Results: Breast cancer in these patients mostly was diagnosed at early (79.0% stages I or II) or locally advanced (16.1% stage III) stages. The primary tumor was resected in 89.0% of cases, most often through breast-conserving surgery (55.1%). Patients with locally advanced disease received more aggressive therapy (eg, higher rates of mastectomy, axillary dissection and chemotherapy use) than patients with early-stage disease. The estimated 2-year overall survival (OS) was 95.3%. Survival was significantly longer among patients with stage I or II disease (2-year OS, 97.9% and 97.5%, respectively) than those with stage III or IV disease (89.4% and 69.5%, respectively; P < .01). Tumor grade was also correlated with OS in the overall cohort (P = .05); triple-negative status was only prognostic for patients with stage III disease (P < .01). Conclusion: The data provided aid understanding of the current scenario of breast cancer presentation and treatment in the Brazilian private health care system and may serve as a foundation to guide resource allocation. Our results reinforce the need to pursue adequate access to cancer care in low- and middle-income countries to optimize patient outcome.http://ascopubs.org/doi/10.1200/JGO.17.00143
spellingShingle Alexandre Boukai
Aline C. Gonçalves
Monica Padoan
Perla Andrade
Natalia Carvalho
Flavio Lemos
Thamires Almeida
Jonas Salem
Maria F. D. Gauí
Nelson Teich
Luiz H. Araujo
Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
Journal of Global Oncology
title Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
title_full Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
title_fullStr Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
title_full_unstemmed Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
title_short Outcome of Patients With Breast Cancer Treated in a Private Health Care Institution in Brazil
title_sort outcome of patients with breast cancer treated in a private health care institution in brazil
url http://ascopubs.org/doi/10.1200/JGO.17.00143
work_keys_str_mv AT alexandreboukai outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT alinecgoncalves outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT monicapadoan outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT perlaandrade outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT nataliacarvalho outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT flaviolemos outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT thamiresalmeida outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT jonassalem outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT mariafdgaui outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT nelsonteich outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil
AT luizharaujo outcomeofpatientswithbreastcancertreatedinaprivatehealthcareinstitutioninbrazil